Treace Medical Concepts develops specialized surgical systems and implants for the correction of bunions and midfoot deformities, notably the Lapiplasty 3D Bunion Correction system that addresses the three-dimensional deformity and stabilizes the unstable joint at its root cause. The portfolio includes midfoot correction systems, minimally invasive bunion correction options and rapid compression fixation devices. Its products are used by foot and ankle surgeons to achieve more reproducible anatomic corrections and better patient outcomes.
| Quarter | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| Q1 2025 | 52.6 | — | -15.9 | — |
| Q2 2025 | 47.4 | — | -17.4 | — |
| Q3 2025 | 50.2 | — | -16.3 | — |
| Q4 2025 | 62.5 | — | -9.4 | — |
| Q1 2026 | 47.2 | -10.2% | -18 | — |
| Q2 2026 | 45.4 | -4.2% | -15.9 | — |
All markets — KeepWinning global stock screener
Other companies on Nasdaq: Ramaco Resources, Inc. (METCB), A2Z Cust2Mate Solutions Corp. (AZ), Angi Inc. (ANGI), Oceanhawk Acquisition Corp (OHAC), Kolibri Global Energy Inc. (KGEI), QDRO Acquisition Corp. (QADR)